Cohen Children’s Medical Center’s comprehensive stem cell transplant program recently underwent a successful three-year accreditation renewal by the Foundation for the Accreditation of Cellular Therapy (FACT).
This accreditation applies to all services and facilities at Cohen that were inspected by FACT, specifically Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Marrow and Peripheral Blood Product Collection, and Cellular Therapy Product Processing.
The Hematopoietic Stem Cell Transplant (HSCT) program has been an integral part of the Division of Hematology/Oncology and Stem Cell Transplantation since 1991 and has made possible hundreds of successful stem cell transplants for a wide variety of malignant and nonmalignant disorders.
Patients are treated in the Gambino Medical and Science Foundation Bone Marrow Transplantation Unit by an interdisciplinary team of medical professionals that includes attending physicians, nurse practitioners, social workers and child life therapists, nutritionists and others, all of whom coordinate their efforts for the benefit of their young patients.
The program performs both autologous and allogenic stem cell transplants. Autologous stem cell transplantation involves patients using their own stem cells. This modality is used predominately for patients diagnosed with solid tumors, as well as patients with Hodgkin/non-Hodgkin lymphomas.
An allogenic hematopoietic stem cell transplant is a transplant from a donor who is immunologically compatible with the patient and involves matching a patient’s tissue type, specifically their human leukocyte antigen (HLA) type, with that of a related or unrelated donor.
“We are thrilled to once again successfully renew our accreditation by the Foundation for Accreditation of Cellular Therapy,” said Joel A. Brochstein, MD, FAAP, Associate Chief for Cellular Therapy for the Division of Hematology/Oncology and Stem Cell Transplantation at Cohen. “FACT accreditation hinges upon demonstrating excellent clinical practices that maximize the effectiveness of our transplants while also ensuring the well-being of our young patients. Successful accreditation demands a team effort that involves physicians, nurses, technologists, social workers, physical therapists and child life therapists. I am very proud of all of them.”
For more information about the Hematopoietic Stem Cell Transplant Program at Cohen, please call (718) 470-3460.
# # #
About the Steven and Alexandra Cohen Children’s Medical Center of New York
Founded in 1983, Cohen Children’s Medical Center is a 202-bed hospital dedicated exclusively to the care of children. The specialists in the hospital’s national and international programs cover an entire range of specialties. State-of-the-art care for children’s medical, surgical, and dental needs are provided in both inpatient and outpatient settings. The facility is the largest provider of pediatric health services in New York State, serving 1.8 million children in Brooklyn, Queens, and Nassau and Suffolk Counties. For the 11th consecutive year in 2017, Cohen’s was ranked among the nation’s best children’s hospitals in U.S. News & World Report's 2017-18 “America’s Best Children’s Hospitals” survey, achieving top-50 rankings in nine of 10 pediatric specialties.